Elutia (ELUT) said Monday it has agreed to a national group purchasing contract for its EluPro antibiotic-eluting cardiac implant with Premier (PINC), allowing Premier members to take advantage of special pre-negotiated pricing for the heart rhythm management device.

Financial terms and other details of the new contract weren't disclosed.

EluPro was developed to deliver powerful antibiotics directly to the surgical site, helping promote healing and reducing inflammation and scarring by forming a vascularized pocket of the patient's tissue surrounding the implantable device, Elutia said.

Elutia shares recently were up nearly 4% in early trading Monday, while Premier's shares were down 0.7%.

Price: 4.30, Change: +0.16, Percent Change: +3.86